InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,890.84
(
0.00%
)
Post# of 252428
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: DewDiligence post# 186981

Friday, 02/06/2015 9:52:35 PM

Friday, February 06, 2015 9:52:35 PM

Post# of 252428
MRK just posted this non-inferiority ph3 study of 2-DAA FDC vs Sovaldi + PI + R in GT1/4/6. It seems very likely to me FDA had requested comparator non-inferiority study for future HCV drug approval based on their previous comment/guidance:

https://clinicaltrials.gov/ct2/show/NCT02358044
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up